Your account is not claimed yet. You can sign up with ORCID to claim your account.

Haitao Chen

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 2

Top Topics

Dendritic Cells

Ejection Fraction

Top Venues

Alimentary pharmacology & therapeutics

Wake Forest Baptist Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Wake Forest Baptist Medical Center

United States

Research scholar :: Center for Cancer Genomics

Publications

Mengqi Luo, Jia Hou, Haoming Mai, Jiaxuan Chen, Haitao Chen, Bin Zhou, Jinlin Hou, De-Ke Jiang
TRIM26 inhibits hepatitis B virus replication by promoting HBx degradation and TRIM26 genetic polymorphism predicts PegIFNα treatment response of HBeAg-positive chronic hepatitis B Patients. Alimentary pharmacology & therapeutics 56 (5) (2022)
Haitao Chen, Jian Sun, Bin Zhou, Jinxin Peng, Qing Xie, Xieer Liang, Rong Fan, Carly Conran, Jianfeng Xu, Yuan Ji, Xinxin Zhang, Li Sun, Ji-Dong Jia, Guiqiang Wang, Jinlin Hou, De-Ke Jiang
A missense variant in complement factor B (CFB) is a potential predictor of 24-week off-treatment response to PegIFNα therapy in Chinese HBeAg-positive chronic hepatitis B patients. Alimentary pharmacology & therapeutics 51 (4) (2020)